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Abstract
Background Silicone gel-containing breast implants have
been widely used for aesthetic and reconstructive mammo-
plasty. The development of a periprosthetic capsule is con-
sidered a local reparative process against the breast implant
in which a variety of inflammatory cells may appear. Nev-
ertheless, only few reports have evaluated the immunophe-
notypes of those inflammatory cells. Herein, we aim to
provide more information in this regard evaluating 40
patients with breast implants.
Methods We studied the immunophenotype of the inflam-
matory cells of capsular implants using antibodies against
lymphocytes (CD3, CD4, CD8, CD20, CD45, and CD30)
and histiocytes (CD68). Percentages of CD3 and CD20
positive cells were compared using the unpaired Student's t
test. Fisher's test was also used to compare Baker grades by
implant type, implant profile, and location and the presence
of inflammatory cells by implant type.
Results The associations between Baker grades and implant
type and location were statistically nonsignificant (p00.42
in both cases). However, the use of low profile implants was
significantly associated (p00.002) with a higher proportion
of Baker grades 3 and 4. We found evidence of inflamma-
tion in 92.5 % of all implant capsules, with a statistically
significant (p00.036) higher proportion in textured breast
implants. T cells predominated over B cells. Textured
implants elicited a more marked response to T cells than
smooth implants, with a similar proportion of helper and
cytotoxic T cells. Textured implants showed statistically
significant higher percentages of CD3 positive cells than
smooth implants. Percentages of CD20 positive cells were
similar in textured and smooth implants.
Conclusions These results suggest that textured breast
implants might induce a stronger local T cell immune re-
sponse. Our findings could shed some light to understand
the association of silicone breast implants and some cases of
anaplastic large cell lymphomas.
Level of Evidence: Level III, prognostic study.
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Introduction
Silicone gel-containing breast implants have been widely used
for aesthetic and reconstructive mammoplasty. The develop-
ment of a periprosthetic capsule is considered a local repara-
tive process against the breast implant in which a variety of
inflammatory cells may appear. Nevertheless, only few reports
have evaluated the immunophenotypes of those inflammatory
cells. Herein, we aim to provide more information in this
regard evaluating 40 patients with breast implants [1–3]. Our
study focused on capsules with and without capsular contrac-
ture, including replacement of round textured and smooth
breast implants in aesthetic surgery [4]. Characteristics of
inflammatory cells are reported in the present study, along
with the association between lymphocytic and histiocytic
immunophenotypes and clinicopathologic features.
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Materials and methods
This is a prospective study of periprosthetic breast capsules
from 40 consecutive patients (or 80 capsules) with replace-
ment of gel-containing breast implants for aesthetic aug-
mentation between March 2008 and December 2010.
Capsular contracture was graded following the Baker
scale method, ranging from 1 to 4. The new implant type
was chosen by the patient and the plastic surgeon based on
preoperative breast size and chest dimensions. Gel-
containing breast implants were replaced regardless of type
(textured or smooth) or profile (high or low). In each case,
the anesthesia was either general or thoracic epidural [5, 6].
A periareolar approach was carried out to remove the pre-
vious implant. In all cases, the new implant was smooth,
round, and of high profile, placed in a submuscular location.
A liquid sample of the virtual capsular space was taken for
microbiologic culture. The entire capsular implant or a repre-
sentative fraction of it was fixed in 10% buffered formalin and
sent for pathologic analysis. A negative vacuum drain left
during the surgery was removed at 4th or 5th postoperative
day depending on the quantity and quality of the liquid
drained. Antibiotics were used in each patient as follows:
1 g of cefazolin before surgery, 1 g of cefazolin before intro-
ducing the implants, and a final dose of cefaloxim 1 g 8 h after
surgery [7, 8]. Also, mild thoracic compression with bandage
was used to cover the surgical area.
Hematoxylin and eosin-stained slides were prepared from
routinely processed capsular biopsies or excision specimens.
For immunohistochemical stains, sections were cut at 3 μm
and mounted on silane-coated slides. Sections were depar-
affinized and rehydrated. Endogenous peroxidase activity
was blocked by 3 % hydrogen peroxide for 10 min. Antigen
retrieval was performed in 10 mM sodium citrate buffer
(ph 6) for 15 min. Tissue sections were incubated with IgG
monoclonal antibodies directed against CD3, CD4, CD8,
CD20, CD45, CD30, and CD68 (1 h at room temperature).
After incubation, specimens were washed with phosphate
buffered saline (PBS)-tween buffer. The secondary biotiny-
lated antibody was applied, followed by the streptavidin–
biotin–peroxidase complex. Samples were then washed with
PBS-tween buffer and incubated with freshly prepared diami-
nobenzydine (DAB) + substrate–chromogen buffer at room
temperature. After gently rinsing with distilled H2O, slides
were counterstained with hematoxylin and mounted with per-
manent media. Both positive and negative controls were in-
cluded for each immunohistochemical batch.
Statistical analysis
Percentages of CD3 and CD20 positive cells were compared
using the unpaired Student's t test. Baker grades were com-
pared by implant type, implant profile, and location using
the Fisher's exact test. Fisher's test was also used to compare
presence of inflammatory cells by implant type. A two tailed
p<0.05 was required for statistical significance. Data were
analyzed using STATA release 11 (StataCorp Inc., College
Station, TX, USA).
Results
All patients were females with an age range of 22 to 45 years
(median 36.5 years). All patients were healthy without
Fig. 1 a Female, 35 year-old, preoperative view, with capsular con-
tracture, Baker IV. b postoperative view, 7 months after breast surgery
Fig. 2 Breast textured implant with periprosthetic capsule
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aggravating factors except one patient who had a mycobac-
terium infection following her first breast implant. In 25
cases, the presence of contracture was the cause of the
replacement (Fig. 1). In the remaining 15 cases, the patient
chose a larger size for the breast implant. The implants were
textured in 35 cases and smooth in the remaining five cases
(Fig. 2). All textured implants were subglandular while the
smooth implants were submuscular. Baker grades 1 and 4
were the most frequent, with 15 and 16 cases, respectively.
Baker grade 3 was documented in two cases and Baker 3
grade in the remaining seven cases. The associations be-
tween Baker grades and implant type and location were
statistically nonsignificant (p00.42 in both cases). However,
the use of low profile implants was significantly associated
(p00.002) with a higher proportion of Baker grades 3 and 4
(Table 1). No bacterial growth was observed in the cultures,
even in the case with a previous mycobacterium infection.
In 37 cases, the pathology study showed inflammatory
infiltrate in the implant capsule (Fig. 3). Among the cases
with inflammation, three of five (60 %) of the implants were
smooth, and 34 of 35 (97 %) were textured. The association
of inflammatory cells with implant type was statistically
significant (p00.036, Fig. 4). Moreover, in 16 cases, we
observed focal presence of granulomas (siliconomas); all
of which but one occurred in textured implants. Lympho-
cytes predominated, with a minor histiocytic component.
The immunohistochemistry showed a predominance of T
cells over B cells (58 vs. 42 %). Textured implants elicited a
more marked response to T cells than smooth implants, with
a similar mean proportion of CD4 and CD8 positive cells
(48 and 52 %, respectively). Textured implants showed
statistically significant higher mean percentages of CD3
positive cells than smooth implants (57 vs. 29 %, p0
0.003, Fig. 5). The mean percentages of CD20 positive cells
were similar in textured and in smooth implants, and the
difference was statistically nonsignificant (40 vs. 31 %, p0
0.29, Fig. 6). CD68 positive histiocytes represented a minor
cell component in all the cases except when siliconomas
were present.
Discussion
Aside from the morphologic features of the fibrous capsule
that surrounds silicone gel breast implants, knowledge about
Table 1 Association of capsular profile (High vs. Low) and capsular
contracture by Baker grades
Baker contracture High proflie (%) Low proflie (%) Total
Grade 1 15 (100) 0 (0) 15
Grade 2 2 (100) 0 (0) 2
Grade 3 3 (42.9) 4 (57.1) 7
Grade 4 8 (50) 8 (50) 17
P (Fisher’s exact)00.002
Fig. 3 a Hematoxylin and
eosin (H & E) section showing
capsular inflammatory infiltrate
(original magnification×200); b
with predominant cd3 + T cell;
c and a similar proportion of
cd4 + T-helper; d and cd8
T-cytotoxic cells (brown stain
in b, c, and d)
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the nature of the inflammatory response is scant. In addition
to a band of dense fibrous tissue, the implant capsule
includes a variable number of inflammatory cells [9]. Neu-
trophils are usually the first cells to arrive to the inflammatory
process, digesting destroyed tissue. Monocytes, which are
also identified, have phagocytic properties, becoming macro-
phages after engulfing any foreign substance. However, if the
size of the particle to be eliminated is great, monocytes coa-
lesce to form multinucleated giant cells. In addition to neu-
trophils and monocytes/macrophages, T and B lymphocytes
are identified early. B cells are involved in the humoral re-
sponse by producing circulating antibodies when they differ-
entiate to plasma cells. T cells are involved in the cellular
immunity. Nevertheless, the relationship between B and T
lymphocytes, as well as the different proportions of T cell
subtypes, has been infrequently reported in capsular implants.
Most of previously published studies, in which an immu-
nophenotype for inflammatory cells in the capsular implants
or fluid taken from the space between the implants and the
surrounding fibrous capsule were determined, showed a
predominance of T cells over B cells [2, 10]. Our findings
are in agreement with those previous reports since the ma-
jority of inflammatory cells present in the implant capsule
were T cells with a similar proportion for helper and
cytotoxic subtypes. Thus, our findings support the hypoth-
esis that silicone may induce a strong local T cell immune
response. Even though the number of smooth-surfaced
implants in our study was limited, they showed a lower
tendency to elicit an inflammatory response. This finding
would have to be confirmed by future studies. On the other
hand, a variety of immunologic diseases (e.g., rheumatic
diseases, including chronic rheumatoid arthritis, systemic
lupus erythematosus, and Sjogren's syndrome, and the re-
cently identified ALK-negative anaplastic large cell lympho-
ma) has been reported in association with breast implants
[11, 12]. Of particular interest is the latter due to its clinical
implications.
Primary lymphoma of the breast usually accounts for less
than 1 % of all non-Hodgkin's lymphomas, and between 0.4
and 1 % of malignant breast neoplasms [13]. Epidemiologic
studies assessing the risk of non-Hodgkin's lymphoma in
women with breast implants found no association between
breast implants and an increased risk of non-Hodgkin's lym-
phoma [14, 15]. However, in 1997, Keech and Crech de-
scribed a case of anaplastic large cell lymphoma negative for
anaplastic lymphoma kinase-1 (ALCL-ALK1 negative) asso-
ciated with a breast implant. Since this first report, 35 cases of
ALCL in women with breast implants have been documented
worldwide, turning it in a rare but emerging entity [16].
Similar to other lymphomas reported in association with
breast implants, ALCL shows, with rare exceptions, a T cell
phenotype. In the present study, we documented a predom-
inance of T cells when the inflammatory cells were present
in the breast implant capsule. This predominance lead us to
believe that there might exist conditions related to either
the capsular component of implants or to the content of
implants that could facilitate the proliferation of T cells over
B cells. On the other hand, reported ALCL cases related to
implants, for which a reference to the type of implants
exists, have always been of textured surface. It is worth
noting that even though the number of smooth surface
implants in our study was limited, a T cell predominance
tendency, as those seen in textured-type implants, was not
Fig. 4 Presence of inflammation and type of breast implant. An
inflammatory response was more frequent in textured implants
Fig. 5 CD3 positive cells and type of breast implant. CD3-positive
cells were more prevalent in textured implants
Fig. 6 CD20-positive cells and type of breast implant. Proportions of
CD20-positive cells were similar in smooth and textured implant
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observed. This fact backs up the hypothesis about smooth
surfaced implants being less selective for Tcells. Although the
relationship between implants and these diseases is still un-
clear, a broader study is needed to confirm the present findings
and determine its relationship with these diseases.
In summary, capsular contracture was associated with im-
plant profile (low vs. high) but no with implant type (smooth
vs. textured) or location (subglandular vs. submuscular). We
also found evidence of inflammation in 92.5 % of all implant
capsules, with a statistically significant higher proportion in
textured breast implants. T cells predominated over B cells.
Textured implants elicited a more marked response to T cells
than smooth implants, with a similar proportion of helper and
cytotoxic T cells. Textured implants showed statistically sig-
nificant higher percentages of CD3 positive cells than smooth
implants. Percentages of CD20 positive cells were similar in
textured and smooth implants. These results suggest that the
silicone present in breast implants might induce a strong local
Tcell immune response. Our findings could shed some light to
understand the association of silicone breast implants and
some cases of anaplastic large cell lymphomas.
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